Moreover, naringenin was shown to have a significant therapeutic effect on Mycoplasma pneumoniae-induced lung injury in mice by inhibiting pulmonary fibrosis and inhibiting the secretion of inflammatory cytokines such as IL-6, IL-1β, TNF-α, and TGF-β [60]. This evidence concerns the gene TGFB1 and pulmonary fibrosis.